Amentum price target raised to $40 from $35 at Citizens

Citizens raised the firm’s price target on Amentum (AMTM) to $40 from $35 and keeps an Outperform rating on the shares. Citizens expects improving fundamentals through CY26, driven by better visibility from awards and backlog conversion tied to broader ecosystem buildout, with upside not dependent on any single reactor design or enrichment winner, and rising demand for complex, multi-decade nuclear infrastructure work, with Amentum among the few providers able to execute the full lifecycle from engineering to operations and decommissioning, the analyst tells investors in a research note.